PLAB 1 Nov 2024 Trends: Pharmacology Updates | MedRevisions
Analyze the November 2024 PLAB 1 exam trends. Discover why deeper pharmacology knowledge, BNF drug interactions, and acute care decision trees are vital to pass.
What changed
- Pharmacology stems tested deeper drug interaction knowledge and contraindication awareness beyond first-line choices.
- Acute care scenarios required multi-step reasoning with sequential decision points rather than single-action answers.
- Several stems combined pharmacology with clinical context, requiring candidates to select treatments considering co-morbidities.
Why it matters for your score
- Surface-level drug knowledge is no longer sufficient when stems test interaction logic and patient-specific contraindications.
- Acute care stems now penalise incomplete management plans, making it essential to practise full pathway reasoning.
Practical checklist
- Build a focused pharmacology revision block covering drug interactions, contraindications, and monitoring requirements.
- Practise acute care stems where you must sequence three or more management steps in correct order.
- Review BNF-aligned prescribing principles for the top 30 exam-relevant medications.
Common questions
Should I memorise every drug interaction for PLAB?
Focus on high-yield interactions that appear in clinical scenarios: anticoagulants with antibiotics, renal-dose adjustments, and common contraindications in pregnancy and renal impairment.
How detailed are the pharmacology stems compared to previous years?
They now test applied knowledge rather than pure recall. Expect stems where you must choose between two drugs based on a specific patient factor, not just name the first-line treatment.
Related updates
Related learning paths
Stay current, stay ready
Every question and note is reviewed by our medical team against the latest guidance. Start practising with content that's kept up-to-date.